JP2008500320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008500320A5 JP2008500320A5 JP2007514117A JP2007514117A JP2008500320A5 JP 2008500320 A5 JP2008500320 A5 JP 2008500320A5 JP 2007514117 A JP2007514117 A JP 2007514117A JP 2007514117 A JP2007514117 A JP 2007514117A JP 2008500320 A5 JP2008500320 A5 JP 2008500320A5
- Authority
- JP
- Japan
- Prior art keywords
- pyrimidin
- thiazol
- methyl
- phenyl
- amine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 50
- 125000000217 alkyl group Chemical group 0.000 claims 48
- 229910005965 SO 2 Inorganic materials 0.000 claims 47
- -1 alkyl-R 9 Chemical group 0.000 claims 39
- 125000003118 aryl group Chemical group 0.000 claims 28
- 125000003710 aryl alkyl group Chemical group 0.000 claims 18
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 16
- 125000003545 alkoxy group Chemical group 0.000 claims 14
- 125000005843 halogen group Chemical group 0.000 claims 11
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims 10
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 9
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 8
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000001424 substituent group Chemical group 0.000 claims 7
- 102000004190 Enzymes Human genes 0.000 claims 6
- 108090000790 Enzymes Proteins 0.000 claims 6
- 125000002723 alicyclic group Polymers 0.000 claims 6
- 239000003814 drug Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000004076 pyridyl group Chemical group 0.000 claims 6
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 claims 5
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 claims 5
- 150000004292 cyclic ethers Chemical class 0.000 claims 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 5
- 208000035475 disorder Diseases 0.000 claims 5
- WMYBWPZOKYUYHQ-UHFFFAOYSA-N 1-[4-[3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 WMYBWPZOKYUYHQ-UHFFFAOYSA-N 0.000 claims 4
- ZBYYPNTVDDUJTC-UHFFFAOYSA-N 1-[4-[4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(N)S2)C)=N1 ZBYYPNTVDDUJTC-UHFFFAOYSA-N 0.000 claims 4
- RPMKNQKYFFKBAZ-UHFFFAOYSA-N 1-[4-[4-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCN(CC2)C(C)=O)=N1 RPMKNQKYFFKBAZ-UHFFFAOYSA-N 0.000 claims 4
- DOBOZMUVNVYNLF-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-methyl-4-piperidin-1-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(N3CCCCC3)=CC=2)=N1 DOBOZMUVNVYNLF-UHFFFAOYSA-N 0.000 claims 4
- KKZLCEABFUFJHM-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-methylsulfonylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(C)(=O)=O)=N1 KKZLCEABFUFJHM-UHFFFAOYSA-N 0.000 claims 4
- YNNLNAPIIVWREC-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-piperazin-1-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)N2CCNCC2)=N1 YNNLNAPIIVWREC-UHFFFAOYSA-N 0.000 claims 4
- GGVWWYJGNSVOOQ-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-piperidin-1-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCCCC2)=N1 GGVWWYJGNSVOOQ-UHFFFAOYSA-N 0.000 claims 4
- MSLDXLIUSOSHSA-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-thiomorpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCSCC2)=N1 MSLDXLIUSOSHSA-UHFFFAOYSA-N 0.000 claims 4
- GMRHSZXJSJNDHZ-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-[3-(morpholin-4-ylmethyl)phenyl]pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CN3CCOCC3)C=CC=2)=N1 GMRHSZXJSJNDHZ-UHFFFAOYSA-N 0.000 claims 4
- SXGSWCDDSRJDTO-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-[4-methoxy-3-(morpholin-4-ylmethyl)phenyl]pyrimidin-2-amine Chemical compound C1=C(CN2CCOCC2)C(OC)=CC=C1NC(N=1)=NC=CC=1C=1SC(C)=NC=1C SXGSWCDDSRJDTO-UHFFFAOYSA-N 0.000 claims 4
- YJJKMZKHSQMMTM-UHFFFAOYSA-N 4-[4-methyl-2-(thiophen-2-ylsulfonylmethyl)-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C(C)N=C1CS(=O)(=O)C1=CC=CS1 YJJKMZKHSQMMTM-UHFFFAOYSA-N 0.000 claims 4
- QOBGKWWRAPVAHZ-UHFFFAOYSA-N 4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-2-(morpholin-4-ylmethyl)phenol Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CN3CCOCC3)C(O)=CC=2)=N1 QOBGKWWRAPVAHZ-UHFFFAOYSA-N 0.000 claims 4
- YGXOMEYMYMUEEV-UHFFFAOYSA-N 4-methyl-5-[2-(3-methyl-4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C)C(N4CCCCC4)=CC=3)N=CC=2)=C1C YGXOMEYMYMUEEV-UHFFFAOYSA-N 0.000 claims 4
- WIRNEQAIBUAVLP-UHFFFAOYSA-N 4-methyl-5-[2-(4-piperazin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCNCC3)N=CC=2)=C1C WIRNEQAIBUAVLP-UHFFFAOYSA-N 0.000 claims 4
- XGOQGRONEKZZQT-UHFFFAOYSA-N 4-methyl-5-[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCCCC3)N=CC=2)=C1C XGOQGRONEKZZQT-UHFFFAOYSA-N 0.000 claims 4
- AJVAMKMZGVKFMK-UHFFFAOYSA-N 4-methyl-5-[2-(4-thiomorpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCSCC3)N=CC=2)=C1C AJVAMKMZGVKFMK-UHFFFAOYSA-N 0.000 claims 4
- LRWFZAGCWBXQDC-UHFFFAOYSA-N 4-n-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-1-n-methyl-2-(trifluoromethyl)benzene-1,4-diamine Chemical compound C1=C(C(F)(F)F)C(NC)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 LRWFZAGCWBXQDC-UHFFFAOYSA-N 0.000 claims 4
- YOLKAZLNKSERGQ-UHFFFAOYSA-N 5-[2-(3-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C=1C=C(N2CCOCC2)C(OC)=CC=1NC(N=1)=NC=CC=1C=1SC(N)=NC=1C YOLKAZLNKSERGQ-UHFFFAOYSA-N 0.000 claims 4
- OOCUBFRMWPHCEE-UHFFFAOYSA-N 5-[2-[4-(4-benzylpiperazin-1-yl)anilino]pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCN(CC=3C=CC=CC=3)CC2)=N1 OOCUBFRMWPHCEE-UHFFFAOYSA-N 0.000 claims 4
- 108091007914 CDKs Proteins 0.000 claims 4
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 4
- ZDNIYSVIOJWIRR-UHFFFAOYSA-N [3-(hydroxymethyl)-5-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methanol Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(CO)C=C(CO)C=2)=N1 ZDNIYSVIOJWIRR-UHFFFAOYSA-N 0.000 claims 4
- ZYHPYQACTSXUDE-UHFFFAOYSA-N [3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-5-(hydroxymethyl)phenyl]methanol Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CO)C=C(CO)C=2)=N1 ZYHPYQACTSXUDE-UHFFFAOYSA-N 0.000 claims 4
- LJKQHMFUGPKGDU-UHFFFAOYSA-N [4-methyl-5-[2-(3-methyl-4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-yl]methanol Chemical compound N1=C(CO)SC(C=2N=C(NC=3C=C(C)C(N4CCCCC4)=CC=3)N=CC=2)=C1C LJKQHMFUGPKGDU-UHFFFAOYSA-N 0.000 claims 4
- GQSACQZGAVTUSA-UHFFFAOYSA-N [4-methyl-5-[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-yl]methanol Chemical compound N1=C(CO)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCCCC3)N=CC=2)=C1C GQSACQZGAVTUSA-UHFFFAOYSA-N 0.000 claims 4
- HSLPGZVMVMTNLG-UHFFFAOYSA-N [5-[2-(3-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]methanol Chemical compound C=1C=C(N2CCOCC2)C(OC)=CC=1NC(N=1)=NC=CC=1C=1SC(CO)=NC=1C HSLPGZVMVMTNLG-UHFFFAOYSA-N 0.000 claims 4
- 125000001931 aliphatic group Polymers 0.000 claims 4
- 125000004122 cyclic group Chemical group 0.000 claims 4
- HVESLTJNPMAQNR-UHFFFAOYSA-N cyclopropyl-[4-[4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]methanone Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCN(CC2)C(=O)C2CC2)=N1 HVESLTJNPMAQNR-UHFFFAOYSA-N 0.000 claims 4
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 4
- 125000001033 ether group Chemical group 0.000 claims 4
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 125000000623 heterocyclic group Chemical group 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- BFQBIVCJNIEQPK-UHFFFAOYSA-N n,4-dimethyl-5-[2-(3-methylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(C)(=O)=O)=N1 BFQBIVCJNIEQPK-UHFFFAOYSA-N 0.000 claims 4
- VLPMVKQWBBVWGZ-UHFFFAOYSA-N n,4-dimethyl-5-[2-(3-piperazin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)N2CCNCC2)=N1 VLPMVKQWBBVWGZ-UHFFFAOYSA-N 0.000 claims 4
- YLBFCKJSKYBEIA-UHFFFAOYSA-N n,4-dimethyl-5-[2-(4-methylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=N1 YLBFCKJSKYBEIA-UHFFFAOYSA-N 0.000 claims 4
- CHWONMDPHRERMK-UHFFFAOYSA-N n,4-dimethyl-5-[2-[4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCN(C)CC2)=N1 CHWONMDPHRERMK-UHFFFAOYSA-N 0.000 claims 4
- QWDFRAOGDXXNAM-UHFFFAOYSA-N n-(3-methoxy-4-morpholin-4-ylphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound C=1C=C(N2CCOCC2)C(OC)=CC=1NC(N=1)=NC=CC=1C(=C(N=1)C)SC=1C1=CC=CN=C1 QWDFRAOGDXXNAM-UHFFFAOYSA-N 0.000 claims 4
- OJNPFEPSIXIFKN-UHFFFAOYSA-N n-[4-(2,6-dimethylmorpholin-4-yl)phenyl]-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound C1C(C)OC(C)CN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 OJNPFEPSIXIFKN-UHFFFAOYSA-N 0.000 claims 4
- ZSIXBFIBEOQNSX-UHFFFAOYSA-N n-[[3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]-1,1,1-trifluoromethanesulfonamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CNS(=O)(=O)C(F)(F)F)C=CC=2)=N1 ZSIXBFIBEOQNSX-UHFFFAOYSA-N 0.000 claims 4
- VDMDIBJEXQVBAV-UHFFFAOYSA-N n-[[3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]benzamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CNC(=O)C=3C=CC=CC=3)C=CC=2)=N1 VDMDIBJEXQVBAV-UHFFFAOYSA-N 0.000 claims 4
- SGOOKXXNYMRRDT-UHFFFAOYSA-N n-[[3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]methanesulfonamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CNS(C)(=O)=O)C=CC=2)=N1 SGOOKXXNYMRRDT-UHFFFAOYSA-N 0.000 claims 4
- MKZYCKFHJVCYGG-UHFFFAOYSA-N n-[[3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]-1,1,1-trifluoromethanesulfonamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(CNS(=O)(=O)C(F)(F)F)C=CC=3)N=CC=2)=C1C MKZYCKFHJVCYGG-UHFFFAOYSA-N 0.000 claims 4
- KDRXPXTYLVINKS-UHFFFAOYSA-N n-[[3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]methanesulfonamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(CNS(C)(=O)=O)C=CC=3)N=CC=2)=C1C KDRXPXTYLVINKS-UHFFFAOYSA-N 0.000 claims 4
- QHONPBKEQDOAJS-UHFFFAOYSA-N n-[[3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]-1,1,1-trifluoromethanesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(CNS(=O)(=O)C(F)(F)F)C=CC=2)=N1 QHONPBKEQDOAJS-UHFFFAOYSA-N 0.000 claims 4
- VDUVNFOVCLKZJU-UHFFFAOYSA-N n-[[3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]methanesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(CNS(C)(=O)=O)C=CC=2)=N1 VDUVNFOVCLKZJU-UHFFFAOYSA-N 0.000 claims 4
- IMPXANVMKWVJJQ-UHFFFAOYSA-N n-[[4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)C)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 IMPXANVMKWVJJQ-UHFFFAOYSA-N 0.000 claims 4
- ZGIRUXCIRPWULG-UHFFFAOYSA-N n-[[4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)C)=CC=C1NC1=NC=CC(C2=C(N=C(N)S2)C)=N1 ZGIRUXCIRPWULG-UHFFFAOYSA-N 0.000 claims 4
- VEJCMMPVTMQFME-UHFFFAOYSA-N n-[[4-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(CNC(C)=O)=CC=2)=N1 VEJCMMPVTMQFME-UHFFFAOYSA-N 0.000 claims 4
- IZUCAZPNDUNAOT-UHFFFAOYSA-N n-[[4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(CNC(C)=O)=CC=2)=N1 IZUCAZPNDUNAOT-UHFFFAOYSA-N 0.000 claims 4
- FIIVFWBKGOOXBG-UHFFFAOYSA-N n-benzyl-4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C(C)N=C1NCC1=CC=CC=C1 FIIVFWBKGOOXBG-UHFFFAOYSA-N 0.000 claims 4
- WBZISVWUTDVGGZ-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(3-methyl-4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(N3CCCCC3)=CC=2)=N1 WBZISVWUTDVGGZ-UHFFFAOYSA-N 0.000 claims 4
- XUKYEEYMPUGKNF-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(3-methylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(C)(=O)=O)=N1 XUKYEEYMPUGKNF-UHFFFAOYSA-N 0.000 claims 4
- YLZOUCKPNFYBKL-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(4-methylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(C)(=O)=O)=N1 YLZOUCKPNFYBKL-UHFFFAOYSA-N 0.000 claims 4
- GUFQYCOGYHRMAZ-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(4-piperazin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCNCC2)=N1 GUFQYCOGYHRMAZ-UHFFFAOYSA-N 0.000 claims 4
- SEDNPAMEXQDTDN-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(4-piperidin-1-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCCCC2)=N1 SEDNPAMEXQDTDN-UHFFFAOYSA-N 0.000 claims 4
- IULWJMBPGCCACX-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(4-thiomorpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCSCC2)=N1 IULWJMBPGCCACX-UHFFFAOYSA-N 0.000 claims 4
- VNHYQYPOPAKUSF-UHFFFAOYSA-N n-ethyl-5-[2-(3-methoxy-4-morpholin-4-ylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(OC)C(N3CCOCC3)=CC=2)=N1 VNHYQYPOPAKUSF-UHFFFAOYSA-N 0.000 claims 4
- BFVATTPOPABDOP-UHFFFAOYSA-N n-ethyl-n,4-dimethyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(N(C)CC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCOCC2)=N1 BFVATTPOPABDOP-UHFFFAOYSA-N 0.000 claims 4
- 108090000765 processed proteins & peptides Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- ZOMIHFOYONJRJB-UHFFFAOYSA-N 1-[4-[3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)N2CCN(CC2)C(C)=O)=N1 ZOMIHFOYONJRJB-UHFFFAOYSA-N 0.000 claims 3
- 102000003989 Aurora kinases Human genes 0.000 claims 3
- 108090000433 Aurora kinases Proteins 0.000 claims 3
- 108091007911 GSKs Proteins 0.000 claims 3
- 102000038624 GSKs Human genes 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 230000002062 proliferating effect Effects 0.000 claims 3
- QLKJBRDTHFWQEM-UHFFFAOYSA-N 1-[4-[4-[[4-(2-anilino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(NC=3C=CC=CC=3)S2)C)=N1 QLKJBRDTHFWQEM-UHFFFAOYSA-N 0.000 claims 2
- NCMYVERLHGKOAK-UHFFFAOYSA-N 1-[4-[4-[[4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2C=NC=CC=2)C)=N1 NCMYVERLHGKOAK-UHFFFAOYSA-N 0.000 claims 2
- LKLWKLSHKBYATH-UHFFFAOYSA-N 1-[4-[4-[[4-[2-[benzyl(methyl)amino]-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound N=1C(C)=C(C=2N=C(NC=3C=CC(=CC=3)N3CCN(CC3)C(C)=O)N=CC=2)SC=1N(C)CC1=CC=CC=C1 LKLWKLSHKBYATH-UHFFFAOYSA-N 0.000 claims 2
- WWDBCOFSUSWIRI-UHFFFAOYSA-N 1-[4-[4-[[4-[4-methyl-2-(2-phenylethylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(NCCC=3C=CC=CC=3)S2)C)=N1 WWDBCOFSUSWIRI-UHFFFAOYSA-N 0.000 claims 2
- YXDTZLUVKWAJGZ-UHFFFAOYSA-N 1-[4-[4-[[4-[4-methyl-2-(4-morpholin-4-ylphenyl)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2C=CC(=CC=2)N2CCOCC2)C)=N1 YXDTZLUVKWAJGZ-UHFFFAOYSA-N 0.000 claims 2
- LZCVCEPISTVVDN-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]acetamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC(=O)CC=2C=CC(Cl)=CC=2)=N1 LZCVCEPISTVVDN-UHFFFAOYSA-N 0.000 claims 2
- PJERCJCIXYAWDW-UHFFFAOYSA-N 2-(4-chlorophenyl)-n-[4-[2-(dimethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]acetamide Chemical compound S1C(N(C)C)=NC(C)=C1C1=CC=NC(NC(=O)CC=2C=CC(Cl)=CC=2)=N1 PJERCJCIXYAWDW-UHFFFAOYSA-N 0.000 claims 2
- BUJKBZKGTVBPGO-UHFFFAOYSA-N 2-[4-[4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]-n-propan-2-ylacetamide Chemical compound C1CN(CC(=O)NC(C)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 BUJKBZKGTVBPGO-UHFFFAOYSA-N 0.000 claims 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 claims 2
- WKTVPPHWQCSJNL-UHFFFAOYSA-N 2-methoxyethyl 2-[3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]acetate Chemical compound COCCOC(=O)CC1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 WKTVPPHWQCSJNL-UHFFFAOYSA-N 0.000 claims 2
- CEOGHUFWUXLNFI-UHFFFAOYSA-N 2-methoxyethyl 2-[3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]acetate Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(CC(=O)OCCOC)C=CC=2)=N1 CEOGHUFWUXLNFI-UHFFFAOYSA-N 0.000 claims 2
- AEFZZKBPRLZWEQ-UHFFFAOYSA-N 2-methoxyethyl 2-[3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]acetate Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(CC(=O)OCCOC)C=CC=2)=N1 AEFZZKBPRLZWEQ-UHFFFAOYSA-N 0.000 claims 2
- LKQVGJAARVKDHU-UHFFFAOYSA-N 3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCCO)=N1 LKQVGJAARVKDHU-UHFFFAOYSA-N 0.000 claims 2
- PZFKBISGJKEYSB-UHFFFAOYSA-N 3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound COCCNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 PZFKBISGJKEYSB-UHFFFAOYSA-N 0.000 claims 2
- JAHLCZRCFROZJE-UHFFFAOYSA-N 3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 JAHLCZRCFROZJE-UHFFFAOYSA-N 0.000 claims 2
- YNUAGHMOARFTOW-UHFFFAOYSA-N 3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C=CC=3)S(=O)(=O)NCCO)N=CC=2)=C1C YNUAGHMOARFTOW-UHFFFAOYSA-N 0.000 claims 2
- JBOXLGMWEAVPBK-UHFFFAOYSA-N 3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound COCCNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 JBOXLGMWEAVPBK-UHFFFAOYSA-N 0.000 claims 2
- WZGHCPBEOCOZJD-UHFFFAOYSA-N 3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-ethylbenzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 WZGHCPBEOCOZJD-UHFFFAOYSA-N 0.000 claims 2
- MPLSNQAHULTSPR-UHFFFAOYSA-N 3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-methylbenzenesulfonamide Chemical compound CNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 MPLSNQAHULTSPR-UHFFFAOYSA-N 0.000 claims 2
- XUWUFBLYFZULDR-UHFFFAOYSA-N 3-[[4-[2-(2-methoxyethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NCCOC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(N)(=O)=O)=N1 XUWUFBLYFZULDR-UHFFFAOYSA-N 0.000 claims 2
- ZTNVADCRIAZNTA-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCCO)=N1 ZTNVADCRIAZNTA-UHFFFAOYSA-N 0.000 claims 2
- HEJMSGHBEFFVQS-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCCOC)=N1 HEJMSGHBEFFVQS-UHFFFAOYSA-N 0.000 claims 2
- KRFAAMMXBOWXSI-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-methylbenzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC)=N1 KRFAAMMXBOWXSI-UHFFFAOYSA-N 0.000 claims 2
- FJJXBTZAGYJORS-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-propan-2-ylbenzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)C)=N1 FJJXBTZAGYJORS-UHFFFAOYSA-N 0.000 claims 2
- TWVJVNNYNNBYED-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(N)(=O)=O)=N1 TWVJVNNYNNBYED-UHFFFAOYSA-N 0.000 claims 2
- OTPFZAVDWPCJLJ-UHFFFAOYSA-N 3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(N)(=O)=O)=N1 OTPFZAVDWPCJLJ-UHFFFAOYSA-N 0.000 claims 2
- JZFGTIBTHDQTDA-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(2-methyl-4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)C)=N1 JZFGTIBTHDQTDA-UHFFFAOYSA-N 0.000 claims 2
- WOHBHEXSHHPQIV-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 WOHBHEXSHHPQIV-UHFFFAOYSA-N 0.000 claims 2
- BYOPENLWBFNNNS-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-methoxy-4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound C=1C=C(N2CCOCC2)C(OC)=CC=1NC(N=1)=NC=CC=1C=1SC(C)=NC=1C BYOPENLWBFNNNS-UHFFFAOYSA-N 0.000 claims 2
- FNEBWEFHBCRADV-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-methyl-4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(N3CCOCC3)=CC=2)=N1 FNEBWEFHBCRADV-UHFFFAOYSA-N 0.000 claims 2
- ZSPVVQZVCCMOGB-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(3-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)N2CCOCC2)=N1 ZSPVVQZVCCMOGB-UHFFFAOYSA-N 0.000 claims 2
- IPIICOPOXASIMM-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-methoxy-2-methylphenyl)pyrimidin-2-amine Chemical compound CC1=CC(OC)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 IPIICOPOXASIMM-UHFFFAOYSA-N 0.000 claims 2
- KIFAKQTZOPHPBX-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-methyl-3-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C(C)=CC=2)N2CCOCC2)=N1 KIFAKQTZOPHPBX-UHFFFAOYSA-N 0.000 claims 2
- QYBVKPOTSCJIIR-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-methyl-3-morpholin-4-ylsulfonylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C(C)=CC=2)S(=O)(=O)N2CCOCC2)=N1 QYBVKPOTSCJIIR-UHFFFAOYSA-N 0.000 claims 2
- OHUBJYNRZKXNJM-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(4-pyrrolidin-1-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCCC2)=N1 OHUBJYNRZKXNJM-UHFFFAOYSA-N 0.000 claims 2
- PVMQBNNUCWAOAU-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-(5-methoxy-2-methylphenyl)pyrimidin-2-amine Chemical compound COC1=CC=C(C)C(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 PVMQBNNUCWAOAU-UHFFFAOYSA-N 0.000 claims 2
- IKIMLXMGMUHBRO-UHFFFAOYSA-N 4-(2,4-dimethyl-1,3-thiazol-5-yl)-n-[4-(morpholin-4-ylmethyl)phenyl]pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(CN3CCOCC3)=CC=2)=N1 IKIMLXMGMUHBRO-UHFFFAOYSA-N 0.000 claims 2
- NVHPLXZBCLDQRP-UHFFFAOYSA-N 4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)-n-(3,4,5-trimethoxyphenyl)pyrimidin-2-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(S2)C=2C=NC=CC=2)C)=C1 NVHPLXZBCLDQRP-UHFFFAOYSA-N 0.000 claims 2
- BHEMMLNBOSWXPM-UHFFFAOYSA-N 4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 BHEMMLNBOSWXPM-UHFFFAOYSA-N 0.000 claims 2
- VHUXLQLYXBRQHF-UHFFFAOYSA-N 4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)-n-(4-pyrrolidin-1-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCCC1 VHUXLQLYXBRQHF-UHFFFAOYSA-N 0.000 claims 2
- DWJZDTVDXRAQGH-UHFFFAOYSA-N 4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)-n-(4-thiomorpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCSCC1 DWJZDTVDXRAQGH-UHFFFAOYSA-N 0.000 claims 2
- BSVFPDRDFRUTIW-UHFFFAOYSA-N 4-(4-methyl-2-thiophen-2-yl-1,3-thiazol-5-yl)-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2SC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 BSVFPDRDFRUTIW-UHFFFAOYSA-N 0.000 claims 2
- WHQQKHZJGKGILD-UHFFFAOYSA-N 4-(chloromethyl)-n-[4-[2-(dimethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]benzamide Chemical compound S1C(N(C)C)=NC(C)=C1C1=CC=NC(NC(=O)C=2C=CC(CCl)=CC=2)=N1 WHQQKHZJGKGILD-UHFFFAOYSA-N 0.000 claims 2
- VSHSQQGEVOCBET-UHFFFAOYSA-N 4-[2-(2,4-dimethylphenyl)-4-methyl-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C(=CC(C)=CC=2)C)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 VSHSQQGEVOCBET-UHFFFAOYSA-N 0.000 claims 2
- UBVWAJAKFRQBNV-UHFFFAOYSA-N 4-[2-[3-(2-methoxyethoxy)-5-(trifluoromethyl)pyridin-2-yl]-4-methyl-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound COCCOC1=CC(C(F)(F)F)=CN=C1C1=NC(C)=C(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)S1 UBVWAJAKFRQBNV-UHFFFAOYSA-N 0.000 claims 2
- CUSJPRCARRIMQG-UHFFFAOYSA-N 4-[4-methyl-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C1 CUSJPRCARRIMQG-UHFFFAOYSA-N 0.000 claims 2
- GZGKJZGRKPYOCM-UHFFFAOYSA-N 4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCCO)=N1 GZGKJZGRKPYOCM-UHFFFAOYSA-N 0.000 claims 2
- FESYXBVCBFMFGM-UHFFFAOYSA-N 4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NCCOC)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 FESYXBVCBFMFGM-UHFFFAOYSA-N 0.000 claims 2
- ZJIUFQPTWAZXSU-UHFFFAOYSA-N 4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-ethylbenzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NCC)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 ZJIUFQPTWAZXSU-UHFFFAOYSA-N 0.000 claims 2
- NZVIANFXUONPFE-UHFFFAOYSA-N 4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=CC(=CC=3)S(=O)(=O)NCCO)N=CC=2)=C1C NZVIANFXUONPFE-UHFFFAOYSA-N 0.000 claims 2
- BMKHMLOSFHGSCW-UHFFFAOYSA-N 4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NCCOC)=CC=C1NC1=NC=CC(C2=C(N=C(N)S2)C)=N1 BMKHMLOSFHGSCW-UHFFFAOYSA-N 0.000 claims 2
- RQDGPMPATRISII-UHFFFAOYSA-N 4-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-n-benzylbenzenesulfonamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=CC(=CC=3)S(=O)(=O)NCC=3C=CC=CC=3)N=CC=2)=C1C RQDGPMPATRISII-UHFFFAOYSA-N 0.000 claims 2
- DHINNTKCFXHLMX-UHFFFAOYSA-N 4-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-(2-hydroxyethyl)benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCCO)=N1 DHINNTKCFXHLMX-UHFFFAOYSA-N 0.000 claims 2
- BMWLYRVPGUZWDC-UHFFFAOYSA-N 4-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-(2-methoxyethyl)benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCCOC)=N1 BMWLYRVPGUZWDC-UHFFFAOYSA-N 0.000 claims 2
- NSYQZMNTPUYTAI-UHFFFAOYSA-N 4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(N)(=O)=O)=N1 NSYQZMNTPUYTAI-UHFFFAOYSA-N 0.000 claims 2
- XDDJYXJYNJNLEL-UHFFFAOYSA-N 4-methyl-5-[2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 XDDJYXJYNJNLEL-UHFFFAOYSA-N 0.000 claims 2
- AVIVQSJULPCODN-UHFFFAOYSA-N 4-methyl-5-[2-(3-methyl-4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C)C(N4CCOCC4)=CC=3)N=CC=2)=C1C AVIVQSJULPCODN-UHFFFAOYSA-N 0.000 claims 2
- LUPMNXFZYLXVMR-UHFFFAOYSA-N 4-methyl-5-[2-(3-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C=CC=3)S(=O)(=O)N3CCOCC3)N=CC=2)=C1C LUPMNXFZYLXVMR-UHFFFAOYSA-N 0.000 claims 2
- OQWUAZIPUCLTLQ-UHFFFAOYSA-N 4-methyl-5-[2-(4-methyl-3-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C(C)=CC=3)S(=O)(=O)N3CCOCC3)N=CC=2)=C1C OQWUAZIPUCLTLQ-UHFFFAOYSA-N 0.000 claims 2
- XVDMWYFAQWBXJM-UHFFFAOYSA-N 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-(2-phenylethyl)-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C(C)N=C1NCCC1=CC=CC=C1 XVDMWYFAQWBXJM-UHFFFAOYSA-N 0.000 claims 2
- NKJRIFOEXTYVHA-UHFFFAOYSA-N 4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-phenyl-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C(C)N=C1NC1=CC=CC=C1 NKJRIFOEXTYVHA-UHFFFAOYSA-N 0.000 claims 2
- WDHOTEXWBPFBKY-UHFFFAOYSA-N 4-methyl-n-(2-phenylethyl)-5-[2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound COC1=C(OC)C(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(NCCC=3C=CC=CC=3)S2)C)=C1 WDHOTEXWBPFBKY-UHFFFAOYSA-N 0.000 claims 2
- AOBJJOVOCADLPV-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-n,4-dimethyl-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(N)=N1 AOBJJOVOCADLPV-UHFFFAOYSA-N 0.000 claims 2
- UNRGXWOKPTVQPV-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-n,n,4-trimethyl-1,3-thiazol-2-amine Chemical compound S1C(N(C)C)=NC(C)=C1C1=CC=NC(N)=N1 UNRGXWOKPTVQPV-UHFFFAOYSA-N 0.000 claims 2
- IOUXEYWLUIRPPF-UHFFFAOYSA-N 5-(2-aminopyrimidin-4-yl)-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(N)=N1 IOUXEYWLUIRPPF-UHFFFAOYSA-N 0.000 claims 2
- KAFZBYLUGVPMRJ-UHFFFAOYSA-N 5-[2-(1,3-benzodioxol-5-ylamino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C4OCOC4=CC=3)N=CC=2)=C1C KAFZBYLUGVPMRJ-UHFFFAOYSA-N 0.000 claims 2
- SFRABABIZFDSIJ-UHFFFAOYSA-N 5-[2-(1,3-benzodioxol-5-ylamino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C3OCOC3=CC=2)=N1 SFRABABIZFDSIJ-UHFFFAOYSA-N 0.000 claims 2
- HFSYKCPVDYIYER-UHFFFAOYSA-N 5-[2-(3,5-dichloro-4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(Cl)C(N3CCOCC3)=C(Cl)C=2)=N1 HFSYKCPVDYIYER-UHFFFAOYSA-N 0.000 claims 2
- SIADTHKIHZVNGE-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound COC1=CC(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 SIADTHKIHZVNGE-UHFFFAOYSA-N 0.000 claims 2
- POUZVNZXMVCXCI-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-4-methyl-n-(2-phenylethyl)-1,3-thiazol-2-amine Chemical compound COC1=CC(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(NCCC=3C=CC=CC=3)S2)C)=C1 POUZVNZXMVCXCI-UHFFFAOYSA-N 0.000 claims 2
- KEEWXBLNCXGKED-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-4-methyl-n-phenyl-1,3-thiazol-2-amine Chemical compound COC1=CC(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(NC=3C=CC=CC=3)S2)C)=C1 KEEWXBLNCXGKED-UHFFFAOYSA-N 0.000 claims 2
- XLQKXTCXGXOIQQ-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-n,4-dimethyl-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(OC)C=C(OC)C=2)=N1 XLQKXTCXGXOIQQ-UHFFFAOYSA-N 0.000 claims 2
- WDTANTDKYOXPEM-UHFFFAOYSA-N 5-[2-(3,5-dimethoxyanilino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(OC)C=C(OC)C=2)=N1 WDTANTDKYOXPEM-UHFFFAOYSA-N 0.000 claims 2
- HVLYWKYTVLAQBW-UHFFFAOYSA-N 5-[2-(3-bromo-4-methylanilino)pyrimidin-4-yl]-n,4-dimethyl-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(Br)C(C)=CC=2)=N1 HVLYWKYTVLAQBW-UHFFFAOYSA-N 0.000 claims 2
- OCBVLSJECMAGQC-UHFFFAOYSA-N 5-[2-(3-bromoanilino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(Br)C=CC=2)=N1 OCBVLSJECMAGQC-UHFFFAOYSA-N 0.000 claims 2
- UIRWRHMKEIUKET-UHFFFAOYSA-N 5-[2-(3-chloro-4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-(3,5-dichlorophenyl)-n,4-dimethyl-1,3-thiazol-2-amine Chemical compound C=1C(Cl)=CC(Cl)=CC=1N(C)C(S1)=NC(C)=C1C(N=1)=CC=NC=1NC(C=C1Cl)=CC=C1N1CCOCC1 UIRWRHMKEIUKET-UHFFFAOYSA-N 0.000 claims 2
- XFOUALDZRSODNH-UHFFFAOYSA-N 5-[2-(3-chloro-4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(Cl)C(N3CCOCC3)=CC=2)=N1 XFOUALDZRSODNH-UHFFFAOYSA-N 0.000 claims 2
- JGWRJJYQNXXYBW-UHFFFAOYSA-N 5-[2-(4-methoxy-3-methylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1=C(C)C(OC)=CC=C1NC1=NC=CC(C2=C(N=C(N)S2)C)=N1 JGWRJJYQNXXYBW-UHFFFAOYSA-N 0.000 claims 2
- MNBRKVFWULVNKF-UHFFFAOYSA-N 5-[2-(4-methoxy-3-methylanilino)pyrimidin-4-yl]-n,4-dimethyl-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(OC)=CC=2)=N1 MNBRKVFWULVNKF-UHFFFAOYSA-N 0.000 claims 2
- FEFQWKBMPCTGCD-UHFFFAOYSA-N 5-[2-[4-(2,6-dimethylmorpholin-4-yl)anilino]pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CC(C)OC(C)C2)=N1 FEFQWKBMPCTGCD-UHFFFAOYSA-N 0.000 claims 2
- LTPYFLPMAQYNQC-UHFFFAOYSA-N 5-[2-[4-(4-benzylpiperazin-1-yl)anilino]pyrimidin-4-yl]-4-methyl-n-(2-phenylethyl)-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCN(CC=4C=CC=CC=4)CC3)N=CC=2)=C(C)N=C1NCCC1=CC=CC=C1 LTPYFLPMAQYNQC-UHFFFAOYSA-N 0.000 claims 2
- LACIISPXRNIXKD-UHFFFAOYSA-N 5-[2-[4-(4-benzylpiperazin-1-yl)anilino]pyrimidin-4-yl]-4-methyl-n-phenyl-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=CC(=CC=3)N3CCN(CC=4C=CC=CC=4)CC3)N=CC=2)=C(C)N=C1NC1=CC=CC=C1 LACIISPXRNIXKD-UHFFFAOYSA-N 0.000 claims 2
- XDAQPAFEUOICHR-UHFFFAOYSA-N 5-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-2-morpholin-4-ylbenzamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(C(N3CCOCC3)=CC=2)C(N)=O)=N1 XDAQPAFEUOICHR-UHFFFAOYSA-N 0.000 claims 2
- VCOZZNBECSZJEM-UHFFFAOYSA-N 5-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]-2-morpholin-4-ylbenzamide Chemical compound N1=C(N)SC(C=2N=C(NC=3C=C(C(N4CCOCC4)=CC=3)C(N)=O)N=CC=2)=C1C VCOZZNBECSZJEM-UHFFFAOYSA-N 0.000 claims 2
- WIAHPYPYAWMZMJ-UHFFFAOYSA-N 5-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-2-morpholin-4-ylbenzamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C(N3CCOCC3)=CC=2)C(N)=O)=N1 WIAHPYPYAWMZMJ-UHFFFAOYSA-N 0.000 claims 2
- 108090000266 Cyclin-dependent kinases Proteins 0.000 claims 2
- 102000003903 Cyclin-dependent kinases Human genes 0.000 claims 2
- 241000701085 Human alphaherpesvirus 3 Species 0.000 claims 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 claims 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 claims 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims 2
- 101710151245 Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims 2
- 241000700584 Simplexvirus Species 0.000 claims 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 2
- DPEDQMJQDPUPBC-UHFFFAOYSA-N [4-methyl-5-[2-(3-methyl-4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-yl]methanol Chemical compound N1=C(CO)SC(C=2N=C(NC=3C=C(C)C(N4CCOCC4)=CC=3)N=CC=2)=C1C DPEDQMJQDPUPBC-UHFFFAOYSA-N 0.000 claims 2
- YUFSSZBXBVYWOJ-UHFFFAOYSA-N [4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-yl]methanol Chemical compound N1=C(CO)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C1C YUFSSZBXBVYWOJ-UHFFFAOYSA-N 0.000 claims 2
- QJSPGFFROFQDPM-UHFFFAOYSA-N [5-[2-(3-methoxy-4-piperidin-1-ylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]methanol Chemical compound C=1C=C(N2CCCCC2)C(OC)=CC=1NC(N=1)=NC=CC=1C=1SC(CO)=NC=1C QJSPGFFROFQDPM-UHFFFAOYSA-N 0.000 claims 2
- YDOOCBVBRYHLKB-UHFFFAOYSA-N [5-[2-[4-(dimethylamino)anilino]pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-yl]methanol Chemical compound C1=CC(N(C)C)=CC=C1NC1=NC=CC(C2=C(N=C(CO)S2)C)=N1 YDOOCBVBRYHLKB-UHFFFAOYSA-N 0.000 claims 2
- 125000004448 alkyl carbonyl group Chemical group 0.000 claims 2
- 150000001408 amides Chemical class 0.000 claims 2
- 150000001409 amidines Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 2
- 125000000043 benzamido group Chemical group [H]N([*])C(=O)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 150000001719 carbohydrate derivatives Chemical class 0.000 claims 2
- 150000003857 carboxamides Chemical class 0.000 claims 2
- 208000015114 central nervous system disease Diseases 0.000 claims 2
- 238000012875 competitive assay Methods 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 150000002170 ethers Chemical class 0.000 claims 2
- DJMMJAVHBXDXRX-UHFFFAOYSA-N ethyl 2-[3-[[4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]sulfonylamino]phenyl]acetate Chemical compound CCOC(=O)CC1=CC=CC(NS(=O)(=O)C=2C=CC(NC=3N=C(C=CN=3)C3=C(N=C(NC)S3)C)=CC=2)=C1 DJMMJAVHBXDXRX-UHFFFAOYSA-N 0.000 claims 2
- BDJRKFHOGFMYTD-UHFFFAOYSA-N ethyl 4-[4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 BDJRKFHOGFMYTD-UHFFFAOYSA-N 0.000 claims 2
- YPRCCDNXMBMXPJ-UHFFFAOYSA-N n,4-dimethyl-5-[2-(2-methyl-4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)C)=N1 YPRCCDNXMBMXPJ-UHFFFAOYSA-N 0.000 claims 2
- OTACRQCAOBRLAZ-UHFFFAOYSA-N n,4-dimethyl-5-[2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(OC)C(OC)=C(OC)C=2)=N1 OTACRQCAOBRLAZ-UHFFFAOYSA-N 0.000 claims 2
- NNMRZPOMVQNXMS-UHFFFAOYSA-N n,4-dimethyl-5-[2-(4-methyl-3-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C(C)=CC=2)S(=O)(=O)N2CCOCC2)=N1 NNMRZPOMVQNXMS-UHFFFAOYSA-N 0.000 claims 2
- NMUICMGXTPBDAK-UHFFFAOYSA-N n,4-dimethyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-n-pyridin-3-yl-1,3-thiazol-2-amine Chemical compound C=1C=CN=CC=1N(C)C(S1)=NC(C)=C1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 NMUICMGXTPBDAK-UHFFFAOYSA-N 0.000 claims 2
- XPLZQYSEUDSDRJ-UHFFFAOYSA-N n,n-diethyl-4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)N(CC)CC)=CC=C1NC1=NC=CC(C2=C(N=C(NC)S2)C)=N1 XPLZQYSEUDSDRJ-UHFFFAOYSA-N 0.000 claims 2
- SOHYJMKRQNHQNU-UHFFFAOYSA-N n-(1,3-benzodioxol-5-yl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound S1C(C=2N=C(NC=3C=C4OCOC4=CC=3)N=CC=2)=C(C)N=C1C1=CC=CN=C1 SOHYJMKRQNHQNU-UHFFFAOYSA-N 0.000 claims 2
- TVSHKODCQBKHAE-UHFFFAOYSA-N n-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical class S1C(C=2N=C(NC=3C=C4OCCOC4=CC=3)N=CC=2)=C(C)N=C1C1=CC=CN=C1 TVSHKODCQBKHAE-UHFFFAOYSA-N 0.000 claims 2
- AGOZNKPBOBDKBF-UHFFFAOYSA-N n-(2-hydroxyethyl)-3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCCO)=N1 AGOZNKPBOBDKBF-UHFFFAOYSA-N 0.000 claims 2
- KKZQGMRIZATWAR-UHFFFAOYSA-N n-(2-methoxyethyl)-3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCCOC)=N1 KKZQGMRIZATWAR-UHFFFAOYSA-N 0.000 claims 2
- YGHVKFBSWBCSOE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-[[4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound C1=CC(S(=O)(=O)NCCOC)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2C=NC=CC=2)C)=N1 YGHVKFBSWBCSOE-UHFFFAOYSA-N 0.000 claims 2
- RJJOODPRDMSMFW-UHFFFAOYSA-N n-(2-methoxyethyl)-4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCCOC)=N1 RJJOODPRDMSMFW-UHFFFAOYSA-N 0.000 claims 2
- DDXXFYMQASOCAE-UHFFFAOYSA-N n-(2-methoxyethyl)-4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCCOC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCOCC2)=N1 DDXXFYMQASOCAE-UHFFFAOYSA-N 0.000 claims 2
- LGWYQQLCZSKFSS-UHFFFAOYSA-N n-(3,5-dichloro-4-morpholin-4-ylphenyl)-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(Cl)C(N3CCOCC3)=C(Cl)C=2)=N1 LGWYQQLCZSKFSS-UHFFFAOYSA-N 0.000 claims 2
- ZHHLYFRRQCAGSJ-UHFFFAOYSA-N n-(3,5-dichloro-4-morpholin-4-ylphenyl)-4-[4-methyl-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazol-5-yl]pyrimidin-2-amine Chemical compound S1C(C)=NC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=C(Cl)C(N4CCOCC4)=C(Cl)C=3)N=CC=2)=C1 ZHHLYFRRQCAGSJ-UHFFFAOYSA-N 0.000 claims 2
- RIDZMYFVSVJBGX-UHFFFAOYSA-N n-(3,5-dimethoxyphenyl)-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound COC1=CC(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(C)S2)C)=C1 RIDZMYFVSVJBGX-UHFFFAOYSA-N 0.000 claims 2
- XOAYPVYCLLYFCT-UHFFFAOYSA-N n-(3,5-dimethoxyphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound COC1=CC(OC)=CC(NC=2N=C(C=CN=2)C2=C(N=C(S2)C=2C=NC=CC=2)C)=C1 XOAYPVYCLLYFCT-UHFFFAOYSA-N 0.000 claims 2
- AHYZNCKAQMWADI-UHFFFAOYSA-N n-(3-chloro-4-morpholin-4-ylphenyl)-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(Cl)C(N3CCOCC3)=CC=2)=N1 AHYZNCKAQMWADI-UHFFFAOYSA-N 0.000 claims 2
- OTDXZCJDGOEYPJ-UHFFFAOYSA-N n-(3-chloro-4-morpholin-4-ylphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1Cl)=CC=C1N1CCOCC1 OTDXZCJDGOEYPJ-UHFFFAOYSA-N 0.000 claims 2
- IQEKZZNPEGRYDP-UHFFFAOYSA-N n-(3-methoxyphenyl)-3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC=2C=C(OC)C=CC=2)=N1 IQEKZZNPEGRYDP-UHFFFAOYSA-N 0.000 claims 2
- ARYAOOHLSUTMRN-UHFFFAOYSA-N n-(3-methyl-4-piperidin-1-ylphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1C)=CC=C1N1CCCCC1 ARYAOOHLSUTMRN-UHFFFAOYSA-N 0.000 claims 2
- QEYHOQWLGJJWNJ-UHFFFAOYSA-N n-(4-chlorophenyl)-n,4-dimethyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical class C=1C=C(Cl)C=CC=1N(C)C(S1)=NC(C)=C1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 QEYHOQWLGJJWNJ-UHFFFAOYSA-N 0.000 claims 2
- UFUNYSOLFLROAF-UHFFFAOYSA-N n-(4-methoxy-3-methylphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound C1=C(C)C(OC)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2C=NC=CC=2)C)=N1 UFUNYSOLFLROAF-UHFFFAOYSA-N 0.000 claims 2
- HSSIQNYMGPHASH-UHFFFAOYSA-N n-[3-(aminomethyl)phenyl]-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CN)C=CC=2)=N1 HSSIQNYMGPHASH-UHFFFAOYSA-N 0.000 claims 2
- APCHKTVBUYRQTQ-UHFFFAOYSA-N n-[3-(aminomethyl)phenyl]-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC1=CC=CC(CN)=C1 APCHKTVBUYRQTQ-UHFFFAOYSA-N 0.000 claims 2
- RTNMUUJWHBQRAH-UHFFFAOYSA-N n-[3-[[4-(2-amino-4-methyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]sulfonylacetamide Chemical compound CC(=O)NS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(N)S2)C)=C1 RTNMUUJWHBQRAH-UHFFFAOYSA-N 0.000 claims 2
- IAHOWNXAPYQTCW-UHFFFAOYSA-N n-[3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]sulfonylacetamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)=O)=N1 IAHOWNXAPYQTCW-UHFFFAOYSA-N 0.000 claims 2
- JVCBOOGOEWNDPV-UHFFFAOYSA-N n-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)NC1=NC=CC(C2=C(N=C(C)S2)C)=N1 JVCBOOGOEWNDPV-UHFFFAOYSA-N 0.000 claims 2
- QPDLOBKNDHXKJT-UHFFFAOYSA-N n-[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]-2-(4-nitrophenyl)acetamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC(=O)CC=2C=CC(=CC=2)[N+]([O-])=O)=N1 QPDLOBKNDHXKJT-UHFFFAOYSA-N 0.000 claims 2
- KPZPHOOSECPGMX-UHFFFAOYSA-N n-[4-(4-benzylpiperazin-1-yl)phenyl]-4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)N2CCN(CC=3C=CC=CC=3)CC2)=N1 KPZPHOOSECPGMX-UHFFFAOYSA-N 0.000 claims 2
- NBAICBSUYPXOKV-UHFFFAOYSA-N n-[4-[2-(dimethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]-2-(4-methoxyphenyl)acetamide Chemical compound C1=CC(OC)=CC=C1CC(=O)NC1=NC=CC(C2=C(N=C(S2)N(C)C)C)=N1 NBAICBSUYPXOKV-UHFFFAOYSA-N 0.000 claims 2
- NMEUEWRKWDVXCX-UHFFFAOYSA-N n-[4-[2-(dimethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]-2-(4-nitrophenyl)acetamide Chemical compound S1C(N(C)C)=NC(C)=C1C1=CC=NC(NC(=O)CC=2C=CC(=CC=2)[N+]([O-])=O)=N1 NMEUEWRKWDVXCX-UHFFFAOYSA-N 0.000 claims 2
- ZRXAGHNWNJAVAP-UHFFFAOYSA-N n-[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]-2-(4-methoxyphenyl)acetamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC(=O)CC=2C=CC(OC)=CC=2)=N1 ZRXAGHNWNJAVAP-UHFFFAOYSA-N 0.000 claims 2
- ZMEZNDWFVDTUMQ-UHFFFAOYSA-N n-[5-(2-aminopyrimidin-4-yl)-4-methyl-1,3-thiazol-2-yl]-n-ethylacetamide Chemical compound S1C(N(C(C)=O)CC)=NC(C)=C1C1=CC=NC(N)=N1 ZMEZNDWFVDTUMQ-UHFFFAOYSA-N 0.000 claims 2
- ZNKZJVFVQPPQOC-UHFFFAOYSA-N n-[[3-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]pyridine-2-carboxamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=C(CNC(=O)C=3N=CC=CC=3)C=CC=2)=N1 ZNKZJVFVQPPQOC-UHFFFAOYSA-N 0.000 claims 2
- SXHZYGAFYQHVFX-UHFFFAOYSA-N n-[[3-[[4-(4-methyl-2-thiophen-2-yl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(S2)C=2SC=CC=2)C)=C1 SXHZYGAFYQHVFX-UHFFFAOYSA-N 0.000 claims 2
- YHKCLWVQANLILS-UHFFFAOYSA-N n-[[3-[[4-[2-(2-ethylpyridin-4-yl)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C1=NC(CC)=CC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=C(CNC(C)=O)C=CC=3)N=CC=2)=C1 YHKCLWVQANLILS-UHFFFAOYSA-N 0.000 claims 2
- NZLLVFVVQPCEHF-UHFFFAOYSA-N n-[[3-[[4-[2-(benzylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(NCC=3C=CC=CC=3)S2)C)=C1 NZLLVFVVQPCEHF-UHFFFAOYSA-N 0.000 claims 2
- UBKWWPDCMDPQFN-UHFFFAOYSA-N n-[[3-[[4-[2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(S2)C=2C(=CC(=CN=2)C(F)(F)F)Cl)C)=C1 UBKWWPDCMDPQFN-UHFFFAOYSA-N 0.000 claims 2
- PALCECFPEDXKDZ-UHFFFAOYSA-N n-[[3-[[4-[4-methyl-2-(6-methylpyridin-3-yl)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(S2)C=2C=NC(C)=CC=2)C)=C1 PALCECFPEDXKDZ-UHFFFAOYSA-N 0.000 claims 2
- RAEJHMLEFREXOZ-UHFFFAOYSA-N n-[[4-[[4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)C)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2C=NC=CC=2)C)=N1 RAEJHMLEFREXOZ-UHFFFAOYSA-N 0.000 claims 2
- OMVZAWYXKSZLEJ-UHFFFAOYSA-N n-[[4-[[4-[2-(2-ethylpyridin-4-yl)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C1=NC(CC)=CC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=CC(CNC(C)=O)=CC=3)N=CC=2)=C1 OMVZAWYXKSZLEJ-UHFFFAOYSA-N 0.000 claims 2
- GPQQBYQHCMPRHV-UHFFFAOYSA-N n-benzyl-3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCC=2C=CC=CC=2)=N1 GPQQBYQHCMPRHV-UHFFFAOYSA-N 0.000 claims 2
- KYFWXTZMBHZNDA-UHFFFAOYSA-N n-benzyl-4-[[4-(2,4-dimethyl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(C)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCC=2C=CC=CC=2)=N1 KYFWXTZMBHZNDA-UHFFFAOYSA-N 0.000 claims 2
- GYYWSLRQTUUZHN-UHFFFAOYSA-N n-benzyl-4-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCC=2C=CC=CC=2)=N1 GYYWSLRQTUUZHN-UHFFFAOYSA-N 0.000 claims 2
- HHRDLOPUEUXPHY-UHFFFAOYSA-N n-benzyl-4-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=CC(=CC=2)S(=O)(=O)NCC=2C=CC=CC=2)=N1 HHRDLOPUEUXPHY-UHFFFAOYSA-N 0.000 claims 2
- CFVOXSJTYXATDP-UHFFFAOYSA-N n-ethyl-3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NCC)=N1 CFVOXSJTYXATDP-UHFFFAOYSA-N 0.000 claims 2
- PVWVHIIIRKQIRF-UHFFFAOYSA-N n-ethyl-3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound CCNS(=O)(=O)C1=CC=CC(NC=2N=C(C=CN=2)C2=C(N=C(NC)S2)C)=C1 PVWVHIIIRKQIRF-UHFFFAOYSA-N 0.000 claims 2
- KOKWGCJIARADQT-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(2-methyl-4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C(=CC(=CC=2)N2CCOCC2)C)=N1 KOKWGCJIARADQT-UHFFFAOYSA-N 0.000 claims 2
- LNGVCHKMQJKHDR-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(OC)C(OC)=C(OC)C=2)=N1 LNGVCHKMQJKHDR-UHFFFAOYSA-N 0.000 claims 2
- ACRZXMGVDYTCJN-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(3-methyl-4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(N3CCOCC3)=CC=2)=N1 ACRZXMGVDYTCJN-UHFFFAOYSA-N 0.000 claims 2
- NVFCCBBSHZYFFE-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(4-methyl-3-morpholin-4-ylsulfonylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C(C)=CC=2)S(=O)(=O)N2CCOCC2)=N1 NVFCCBBSHZYFFE-UHFFFAOYSA-N 0.000 claims 2
- FEKFZBLGALNXBC-UHFFFAOYSA-N n-ethyl-4-methyl-5-[2-(pyridin-3-ylmethylamino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NCC=2C=NC=CC=2)=N1 FEKFZBLGALNXBC-UHFFFAOYSA-N 0.000 claims 2
- LNCXICJHDFMMMA-UHFFFAOYSA-N n-ethyl-5-[2-(4-methoxy-2-methylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C(=CC(OC)=CC=2)C)=N1 LNCXICJHDFMMMA-UHFFFAOYSA-N 0.000 claims 2
- RHXOPFWSWLIKKZ-UHFFFAOYSA-N n-ethyl-5-[2-(4-methoxy-3-methylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C)C(OC)=CC=2)=N1 RHXOPFWSWLIKKZ-UHFFFAOYSA-N 0.000 claims 2
- QIUMBXBIRXUEPG-UHFFFAOYSA-N n-ethyl-5-[2-(5-methoxy-2-methylanilino)pyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C(=CC=C(OC)C=2)C)=N1 QIUMBXBIRXUEPG-UHFFFAOYSA-N 0.000 claims 2
- YKEMTVGDNWRGJT-UHFFFAOYSA-N n-methyl-3-[[4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]benzenesulfonamide Chemical compound S1C(NC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC)=N1 YKEMTVGDNWRGJT-UHFFFAOYSA-N 0.000 claims 2
- ZQVKKTMQQMTPHS-UHFFFAOYSA-N n-tert-butyl-4-methyl-5-[2-(3-nitroanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(NC(C)(C)C)SC(C=2N=C(NC=3C=C(C=CC=3)[N+]([O-])=O)N=CC=2)=C1C ZQVKKTMQQMTPHS-UHFFFAOYSA-N 0.000 claims 2
- SKHWSQFUWIACNO-UHFFFAOYSA-N n-tert-butyl-4-methyl-5-[2-(4-methyl-3-nitroanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(NC(C)(C)C)SC(C=2N=C(NC=3C=C(C(C)=CC=3)[N+]([O-])=O)N=CC=2)=C1C SKHWSQFUWIACNO-UHFFFAOYSA-N 0.000 claims 2
- CFLXCFXKVHPBON-UHFFFAOYSA-N n-tert-butyl-4-methyl-5-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]-1,3-thiazol-2-amine Chemical compound N1=C(NC(C)(C)C)SC(C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C1C CFLXCFXKVHPBON-UHFFFAOYSA-N 0.000 claims 2
- 239000001301 oxygen Substances 0.000 claims 2
- 229920000570 polyether Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 102000027426 receptor tyrosine kinases Human genes 0.000 claims 2
- 108091008598 receptor tyrosine kinases Proteins 0.000 claims 2
- 125000000565 sulfonamide group Chemical group 0.000 claims 2
- 150000003457 sulfones Chemical class 0.000 claims 2
- 150000003462 sulfoxides Chemical class 0.000 claims 2
- 230000003612 virological effect Effects 0.000 claims 2
- IQGLJEWXDOISGN-UHFFFAOYSA-N 1-[4-[4-[[4-(4-methyl-2-thiophen-2-yl-1,3-thiazol-5-yl)pyrimidin-2-yl]amino]phenyl]piperazin-1-yl]ethanone Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1NC1=NC=CC(C2=C(N=C(S2)C=2SC=CC=2)C)=N1 IQGLJEWXDOISGN-UHFFFAOYSA-N 0.000 claims 1
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 1
- GBTXQAQRZMYVCT-UHFFFAOYSA-N 3-[[4-[2-(ethylamino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]-n-(1-hydroxy-2-methylpropan-2-yl)benzenesulfonamide Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C(C=CC=2)S(=O)(=O)NC(C)(C)CO)=N1 GBTXQAQRZMYVCT-UHFFFAOYSA-N 0.000 claims 1
- XNPYGAZXDQCZNI-UHFFFAOYSA-N 4-[2-(2-ethylpyridin-4-yl)-4-methyl-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound C1=NC(CC)=CC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=CC(=CC=3)N3CCOCC3)N=CC=2)=C1 XNPYGAZXDQCZNI-UHFFFAOYSA-N 0.000 claims 1
- WGZSYSREPOMDEP-UHFFFAOYSA-N 4-[4-methyl-2-(4-morpholin-4-ylphenyl)-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=CC(=CC=2)N2CCOCC2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 WGZSYSREPOMDEP-UHFFFAOYSA-N 0.000 claims 1
- DXTVDZJPGQYZII-UHFFFAOYSA-N 4-[4-methyl-2-(6-methylpyridin-3-yl)-1,3-thiazol-5-yl]-n-(4-morpholin-4-ylphenyl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC(C)=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1)=CC=C1N1CCOCC1 DXTVDZJPGQYZII-UHFFFAOYSA-N 0.000 claims 1
- JVINBTZUMCFCHW-UHFFFAOYSA-N 5-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)pyrimidin-4-yl]-4-methyl-n-(2-phenylethyl)-1,3-thiazol-2-amine Chemical compound S1C(C=2N=C(NC=3C=C4OCCOC4=CC=3)N=CC=2)=C(C)N=C1NCCC1=CC=CC=C1 JVINBTZUMCFCHW-UHFFFAOYSA-N 0.000 claims 1
- WFCHFEOGPJIYJU-UHFFFAOYSA-N 5-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)pyrimidin-4-yl]-n-ethyl-4-methyl-1,3-thiazol-2-amine Chemical compound S1C(NCC)=NC(C)=C1C1=CC=NC(NC=2C=C3OCCOC3=CC=2)=N1 WFCHFEOGPJIYJU-UHFFFAOYSA-N 0.000 claims 1
- 201000004384 Alopecia Diseases 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 102000004000 Aurora Kinase A Human genes 0.000 claims 1
- 108090000461 Aurora Kinase A Proteins 0.000 claims 1
- 102100032306 Aurora kinase B Human genes 0.000 claims 1
- 108090000749 Aurora kinase B Proteins 0.000 claims 1
- 102100026630 Aurora kinase C Human genes 0.000 claims 1
- 108090000805 Aurora kinase C Proteins 0.000 claims 1
- 208000020925 Bipolar disease Diseases 0.000 claims 1
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 claims 1
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims 1
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 claims 1
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 claims 1
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 claims 1
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 claims 1
- 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 claims 1
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 claims 1
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 claims 1
- 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 claims 1
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 claims 1
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 claims 1
- 102000001267 GSK3 Human genes 0.000 claims 1
- 108060006662 GSK3 Proteins 0.000 claims 1
- 206010018364 Glomerulonephritis Diseases 0.000 claims 1
- 101000715946 Homo sapiens Cyclin-dependent kinase 3 Proteins 0.000 claims 1
- 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 claims 1
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 claims 1
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 claims 1
- 208000019693 Lung disease Diseases 0.000 claims 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 102100031463 Serine/threonine-protein kinase PLK1 Human genes 0.000 claims 1
- 231100000360 alopecia Toxicity 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Substances OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- YFKPOENKJUXEQS-UHFFFAOYSA-N n-(3,5-dichloro-4-morpholin-4-ylphenyl)-4-(4-methyl-2-pyridin-3-yl-1,3-thiazol-5-yl)pyrimidin-2-amine Chemical compound CC=1N=C(C=2C=NC=CC=2)SC=1C(N=1)=CC=NC=1NC(C=C1Cl)=CC(Cl)=C1N1CCOCC1 YFKPOENKJUXEQS-UHFFFAOYSA-N 0.000 claims 1
- GQIMQOQAPDZYFZ-UHFFFAOYSA-N n-(3-chloro-4-morpholin-4-ylphenyl)-4-[4-methyl-2-(2-methyl-1,3-thiazol-4-yl)-1,3-thiazol-5-yl]pyrimidin-2-amine Chemical compound S1C(C)=NC(C=2SC(=C(C)N=2)C=2N=C(NC=3C=C(Cl)C(N4CCOCC4)=CC=3)N=CC=2)=C1 GQIMQOQAPDZYFZ-UHFFFAOYSA-N 0.000 claims 1
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 claims 1
- JFIZCDBJOWLTKX-UHFFFAOYSA-N n-[[3-[[4-[2-(3,5-dichloro-n-methylanilino)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-yl]amino]phenyl]methyl]acetamide Chemical compound C=1C(Cl)=CC(Cl)=CC=1N(C)C(S1)=NC(C)=C1C(N=1)=CC=NC=1NC1=CC=CC(CNC(C)=O)=C1 JFIZCDBJOWLTKX-UHFFFAOYSA-N 0.000 claims 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 230000000414 obstructive effect Effects 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 108010056274 polo-like kinase 1 Proteins 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0411791.7A GB0411791D0 (en) | 2004-05-26 | 2004-05-26 | Compounds |
| GB0411791.7 | 2004-05-26 | ||
| PCT/GB2005/002134 WO2005116025A2 (en) | 2004-05-26 | 2005-05-26 | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008500320A JP2008500320A (ja) | 2008-01-10 |
| JP2008500320A5 true JP2008500320A5 (enExample) | 2008-06-19 |
| JP5026259B2 JP5026259B2 (ja) | 2012-09-12 |
Family
ID=32671118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007514117A Expired - Fee Related JP5026259B2 (ja) | 2004-05-26 | 2005-05-26 | 増殖性障害の治療に有用な２−置換−４−ヘテロアリール−ピリミジン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20090137572A1 (enExample) |
| EP (1) | EP1756098A2 (enExample) |
| JP (1) | JP5026259B2 (enExample) |
| CN (1) | CN1989138A (enExample) |
| AU (1) | AU2005247682A1 (enExample) |
| BR (1) | BRPI0511616A (enExample) |
| CA (1) | CA2566051A1 (enExample) |
| GB (1) | GB0411791D0 (enExample) |
| IL (1) | IL179508A0 (enExample) |
| MX (1) | MXPA06013632A (enExample) |
| WO (1) | WO2005116025A2 (enExample) |
Families Citing this family (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0205690D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| GB0205693D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| GB0205688D0 (en) | 2002-03-09 | 2002-04-24 | Astrazeneca Ab | Chemical compounds |
| JP2005524672A (ja) | 2002-03-09 | 2005-08-18 | アストラゼネカ アクチボラグ | Ｃｄｋ阻害活性を有するイミダゾリル置換ピリミジン誘導体 |
| GB0311274D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| GB0311276D0 (en) | 2003-05-16 | 2003-06-18 | Astrazeneca Ab | Chemical compounds |
| KR20070083836A (ko) * | 2004-10-28 | 2007-08-24 | 아이알엠 엘엘씨 | 헷지혹 경로 조절제로서의 화합물 및 조성물 |
| JP5186219B2 (ja) | 2005-01-25 | 2013-04-17 | エピックス デラウェア， インコーポレイテッド | 置換アリールアミン化合物および５−ｈｔ６調節因子としてのその使用 |
| CN101203500B (zh) * | 2005-01-25 | 2013-08-21 | 格利尼公司 | 取代的芳胺化合物和它们作为5-ht6调节剂的用途 |
| AU2007207743B2 (en) | 2006-01-18 | 2010-07-08 | Amgen Inc. | Thiazole compounds as protein kinase B (PKB) inhibitors |
| WO2007132220A1 (en) * | 2006-05-12 | 2007-11-22 | Cyclacel Limited | Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder |
| WO2007132221A1 (en) * | 2006-05-12 | 2007-11-22 | Cyclacel Limited | Combined anticancer pyrimidine-thiazole aurora kinase inhibitors |
| GB0609530D0 (en) * | 2006-05-12 | 2006-06-21 | Cyclacel Ltd | Combination |
| CA2693473A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
| CA2692713A1 (en) | 2007-07-17 | 2009-01-22 | Amgen Inc. | Heterocyclic modulators of pkb |
| EP2197876A1 (en) * | 2007-08-29 | 2010-06-23 | Glaxosmithkline LLC | Thiazole and oxazole kinase inhibitors |
| ATE510827T1 (de) * | 2007-10-12 | 2011-06-15 | Ingenium Pharmaceuticals Gmbh | Inhibitoren von proteinkinasen |
| EP2231625A4 (en) * | 2007-12-13 | 2010-12-29 | Glaxosmithkline Llc | KINASE INHIBITORS BASED ON THIAZOLE AND OXAZOLE |
| WO2009103032A1 (en) | 2008-02-15 | 2009-08-20 | Rigel Pharmaceuticals, Inc. | Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| GB0805477D0 (en) * | 2008-03-26 | 2008-04-30 | Univ Nottingham | Pyrimidines triazines and their use as pharmaceutical agents |
| UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
| JP6073677B2 (ja) | 2009-06-12 | 2017-02-01 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 縮合複素環式化合物およびそれらの使用 |
| JP2013506687A (ja) | 2009-09-30 | 2013-02-28 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | オートファジー促進遺伝子産物の変調によりオートファジーを変調する方法 |
| WO2011059610A1 (en) * | 2009-11-10 | 2011-05-19 | Glaxosmithkline Llc | Benzene sulfonamide thiazole and oxazole compounds |
| CA2784807C (en) | 2009-12-29 | 2021-12-14 | Dana-Farber Cancer Institute, Inc. | Type ii raf kinase inhibitors |
| EP2678336B1 (en) * | 2011-02-24 | 2016-04-20 | Nerviano Medical Sciences S.r.l. | Thiazolylphenyl-benzenesulfonamido derivatives as kinase inhibitors |
| WO2013059634A1 (en) | 2011-10-20 | 2013-04-25 | The Regents Of The University Of California | Use of cdk9 inhibitors to reduce cartilage degradation |
| CA2856291C (en) | 2011-11-17 | 2020-08-11 | Dana-Farber Cancer Institute, Inc. | Inhibitors of c-jun-n-terminal kinase (jnk) |
| US10112927B2 (en) | 2012-10-18 | 2018-10-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (CDK7) |
| US9758522B2 (en) | 2012-10-19 | 2017-09-12 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged small molecules as inducers of protein degradation |
| US10000483B2 (en) | 2012-10-19 | 2018-06-19 | Dana-Farber Cancer Institute, Inc. | Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof |
| JP6491202B2 (ja) | 2013-10-18 | 2019-03-27 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | サイクリン依存性キナーゼ７（ｃｄｋ７）の多環阻害剤 |
| CA2927917C (en) | 2013-10-18 | 2022-08-09 | Syros Pharmaceuticals, Inc. | Heteroaromatic compounds useful for the treatment of proliferative diseases |
| HRP20190039T1 (hr) | 2014-04-04 | 2019-03-08 | Syros Pharmaceuticals, Inc. | Inhibitori ciklin-ovisne kinaze 7 (cdk7) |
| WO2015164604A1 (en) | 2014-04-23 | 2015-10-29 | Dana-Farber Cancer Institute, Inc. | Hydrophobically tagged janus kinase inhibitors and uses thereof |
| US10017477B2 (en) | 2014-04-23 | 2018-07-10 | Dana-Farber Cancer Institute, Inc. | Janus kinase inhibitors and uses thereof |
| WO2016061144A1 (en) | 2014-10-14 | 2016-04-21 | The Regents Of The University Of California | Use of cdk9 and brd4 inhibitors to inhibit inflammation |
| WO2016105528A2 (en) | 2014-12-23 | 2016-06-30 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 (cdk7) |
| CA2978518C (en) | 2015-03-27 | 2023-11-21 | Nathanael S. Gray | Inhibitors of cyclin-dependent kinases |
| EP3307728A4 (en) | 2015-06-12 | 2019-07-17 | Dana Farber Cancer Institute, Inc. | COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS |
| CN108349964B (zh) * | 2015-08-04 | 2021-06-01 | 常州千红生化制药股份有限公司 | N-(吡啶-2-基)-4-(噻唑-5-基)嘧啶-2-胺类化合物作为治疗性化合物 |
| AU2016319125B2 (en) | 2015-09-09 | 2021-04-08 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinases |
| US11325900B2 (en) | 2018-01-15 | 2022-05-10 | Aucentra Holdings Pty Ltd | 5-(pyrimidin-4-yl)thiazol-2-yl urea derivatives as therapeutic agents |
| WO2020005807A1 (en) | 2018-06-25 | 2020-01-02 | Dana-Farber Cancer Institute, Inc. | Taire family kinase inhibitors and uses thereof |
| CN111039941B (zh) * | 2018-10-12 | 2023-03-21 | 上海医药集团股份有限公司 | 一种含氮杂环化合物、其制备方法及应用 |
| US12281126B2 (en) | 2018-12-28 | 2025-04-22 | Dana-Farber Cancer Institute, Inc. | Inhibitors of cyclin-dependent kinase 7 and uses thereof |
| WO2024259116A1 (en) * | 2023-06-14 | 2024-12-19 | Prothena Biosciences Limited | 5-(cinnolin-6-yl)thiazole compounds for treating neurological disorders |
| CN116903592B (zh) * | 2023-07-13 | 2025-08-01 | 特科罗生物科技(成都)有限公司 | 一种嘧啶胺类nuak抑制剂及其制备方法和用途 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5516775A (en) * | 1992-08-31 | 1996-05-14 | Ciba-Geigy Corporation | Further use of pyrimidine derivatives |
| NZ274978A (en) * | 1993-10-12 | 1998-04-27 | Du Pont Merck Pharma | 1n-alkyl-n-aryl pyrimidinamine derivatives and pharmaceutical compositions thereof |
| GB9519275D0 (en) * | 1995-09-21 | 1995-11-22 | Univ Dundee | Substances and their therapeutic use |
| GB9523675D0 (en) * | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
| DE69736351D1 (de) * | 1996-05-08 | 2006-08-31 | Cyclacel Ltd | Methoden und mittel zur hemmung der cdk4-aktivität |
| US6703395B2 (en) * | 1998-03-04 | 2004-03-09 | Institute Of Experimental Botany Of The Academy Of Sciences Of The Czech Republic | Cyclin dependent kinase inhibitor |
| AU753015B2 (en) * | 1998-03-04 | 2002-10-03 | Cyclacel Limited | Cyclin dependent kinase inhibitor |
| US7045519B2 (en) * | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| AU4956699A (en) * | 1998-06-19 | 2000-01-05 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| GB2361236B (en) * | 2000-03-29 | 2002-04-24 | Cyclacel Ltd | Pyrimidines useful against proliferative disorders |
| GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
| EP1392684B1 (en) * | 2001-06-01 | 2006-09-13 | Vertex Pharmaceuticals Incorporated | Thiazole compounds useful as inhibitors of protein kinases |
| US20040181066A1 (en) * | 2001-08-01 | 2004-09-16 | Fraley Mark E. | Tyrosine kinase inhibitors |
| CN100500663C (zh) * | 2001-09-28 | 2009-06-17 | 西克拉塞尔有限公司 | 作为抗增殖化合物的n-(4-(4-甲基噻唑-5-基)嘧啶-2-基)-n-苯胺 |
| GB0226582D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Anti-viral compounds |
| GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
| GB0229581D0 (en) * | 2002-12-19 | 2003-01-22 | Cyclacel Ltd | Use |
| US20040235834A1 (en) * | 2003-03-25 | 2004-11-25 | Farmer Luc J. | Thiazoles useful as inhibitors of protein kinases |
| EP1648875A1 (en) * | 2003-07-30 | 2006-04-26 | Cyclacel Limited | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors |
| BRPI0412351A (pt) * | 2003-07-30 | 2006-09-05 | Cyclacel Ltd | derivados e piridilamino-pirimidina como inibidores de proteìna quinase |
| CA2542880A1 (en) * | 2003-10-21 | 2005-05-12 | Cyclacel Limited | Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| WO2005113550A1 (ja) * | 2004-05-20 | 2005-12-01 | Mitsubishi Pharma Corporation | アミノピリミジン誘導体及びその医薬としての用途 |
-
2004
- 2004-05-26 GB GBGB0411791.7A patent/GB0411791D0/en not_active Ceased
-
2005
- 2005-05-26 CN CNA2005800241399A patent/CN1989138A/zh active Pending
- 2005-05-26 BR BRPI0511616-3A patent/BRPI0511616A/pt not_active IP Right Cessation
- 2005-05-26 US US11/596,740 patent/US20090137572A1/en not_active Abandoned
- 2005-05-26 EP EP05748147A patent/EP1756098A2/en not_active Withdrawn
- 2005-05-26 JP JP2007514117A patent/JP5026259B2/ja not_active Expired - Fee Related
- 2005-05-26 MX MXPA06013632A patent/MXPA06013632A/es not_active Application Discontinuation
- 2005-05-26 CA CA002566051A patent/CA2566051A1/en not_active Abandoned
- 2005-05-26 AU AU2005247682A patent/AU2005247682A1/en not_active Abandoned
- 2005-05-26 WO PCT/GB2005/002134 patent/WO2005116025A2/en not_active Ceased
-
2006
- 2006-11-22 IL IL179508A patent/IL179508A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008500320A5 (enExample) | ||
| JP2007520540A5 (enExample) | ||
| RU2451673C2 (ru) | ПРОИЗВОДНЫЕ ПИРИДИНА И ПИРИМИДИНА В КАЧЕСТВЕ АНТАГОНИСТОВ mGluR2 | |
| JP2007509117A5 (enExample) | ||
| US20090137572A1 (en) | 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders | |
| RU2008117170A (ru) | Пиримидинамидные соединения как ингибиторы pgds | |
| RU2454415C2 (ru) | Производное индола | |
| JP2008524248A5 (enExample) | ||
| RU2426731C2 (ru) | Производные арил-изоксазоло-4-ил-оксадиазола | |
| JP2007523142A5 (enExample) | ||
| JP2013517273A5 (enExample) | ||
| CA2590939A1 (en) | Aminopyrimidine compounds and methods of use | |
| US20040110810A1 (en) | 2-(3-Aminoaryl)amino-4-aryl-thiazoles for the treatment of diseases | |
| JP2011526616A5 (enExample) | ||
| JP2018048190A (ja) | ヒトプロテインチロシンホスファターゼ阻害剤および使用法 | |
| JP2010215644A5 (enExample) | ||
| JP2015533157A5 (enExample) | ||
| RU2011134631A (ru) | Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний | |
| RU2010115574A (ru) | Замещенные амиды, фармацевтическая композиция на их основе, способ лечения заболевания, чувствительного к btk, способ повышения чувствительности раковых клеток к химиотерапии, способ уменьшения ошибок при приеме лекарства и улучшения соблюдения схемы лечения, способ ингибирования гидролиза атф, способ определения присутствия btk в образце и способ ингибирования активности в-клеток | |
| JP2002332266A (ja) | ＰＰＡＲ−γモジュレータ | |
| JP2009542659A5 (enExample) | ||
| JP2008519850A5 (enExample) | ||
| JP2011523646A5 (enExample) | ||
| JP2007508346A5 (enExample) | ||
| JP2003525872A5 (enExample) |